AstraZeneca must show it is not profiting from vaccine while Covid-19 is pandemic
The price of AstraZeneca’s vaccine candidate has been set at about $3 (R46) per dose, against at least four times more for other candidates
24 November 2020 - 18:11
Brussels — AstraZeneca must provide reassurance that it will not profit from its potential Covid-19 vaccine, nongovernmental organisation Medecins Sans Frontieres (MSF) said on Tuesday, urging the company to make public its supply contracts.
The British firm said on Monday its Covid-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective, giving the world’s fight against the global pandemic a third new weapon that can be cheaper to make, easier to distribute and faster to scale-up than rivals...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.